These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15645285)

  • 21. PMM2-CDG: phenotype and genotype in four affected family members.
    Bortot B; Cosentini D; Faletra F; Biffi S; De Martino E; Carrozzi M; Severini GM
    Gene; 2013 Dec; 531(2):506-9. PubMed ID: 23988505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.
    Schollen E; Keldermans L; Foulquier F; Briones P; Chabas A; Sánchez-Valverde F; Adamowicz M; Pronicka E; Wevers R; Matthijs G
    Mol Genet Metab; 2007 Apr; 90(4):408-13. PubMed ID: 17307006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
    Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
    Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype.
    Monin ML; Mignot C; De Lonlay P; Héron B; Masurel A; Mathieu-Dramard M; Lenaerts C; Thauvin C; Gérard M; Roze E; Jacquette A; Charles P; de Baracé C; Drouin-Garraud V; Khau Van Kien P; Cormier-Daire V; Mayer M; Ogier H; Brice A; Seta N; Héron D
    Orphanet J Rare Dis; 2014 Dec; 9():207. PubMed ID: 25497157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency.
    Shanti B; Silink M; Bhattacharya K; Howard NJ; Carpenter K; Fietz M; Clayton P; Christodoulou J
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S241-51. PubMed ID: 19396570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A previously undescribed form of congenital disorder of glycosylation with variable presentation in siblings: early fetal loss with hydrops fetalis, and infant death with hypoproteinemia.
    McKenzie FA; Fietz M; Fletcher J; Smith RL; Wright IM; Jaeken J
    Am J Med Genet A; 2007 Sep; 143A(17):2029-34. PubMed ID: 17663480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic Kidney Disease with Hyperinsulinemic Hypoglycemia Caused by a Promoter Mutation in Phosphomannomutase 2.
    Cabezas OR; Flanagan SE; Stanescu H; García-Martínez E; Caswell R; Lango-Allen H; Antón-Gamero M; Argente J; Bussell AM; Brandli A; Cheshire C; Crowne E; Dumitriu S; Drynda R; Hamilton-Shield JP; Hayes W; Hofherr A; Iancu D; Issler N; Jefferies C; Jones P; Johnson M; Kesselheim A; Klootwijk E; Koettgen M; Lewis W; Martos JM; Mozere M; Norman J; Patel V; Parrish A; Pérez-Cerdá C; Pozo J; Rahman SA; Sebire N; Tekman M; Turnpenny PD; Hoff WV; Viering DHHM; Weedon MN; Wilson P; Guay-Woodford L; Kleta R; Hussain K; Ellard S; Bockenhauer D
    J Am Soc Nephrol; 2017 Aug; 28(8):2529-2539. PubMed ID: 28373276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
    Quelhas D; Quental R; Vilarinho L; Amorim A; Azevedo L
    Ann Hum Genet; 2007 May; 71(Pt 3):348-53. PubMed ID: 17166182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and molecular studies in 26 Spanish patients with congenital disorder of glycosylation type Ia.
    Briones P; Vilaseca MA; Schollen E; Ferrer I; Maties M; Busquets C; Artuch R; Gort L; Marco M; van Schaftingen E; Matthijs G; Jaeken J; Chabás A
    J Inherit Metab Dis; 2002 Dec; 25(8):635-46. PubMed ID: 12705494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early fatal course in siblings with CDG-Ia (caused by two novel mutations in the PMM2 gene): clinical, molecular and autopsy findings.
    Wurm D; Hänsgen A; Kim YJ; Lindinger A; Baghai A; Gortner L
    Eur J Pediatr; 2007 Apr; 166(4):377-8. PubMed ID: 16941129
    [No Abstract]   [Full Text] [Related]  

  • 31. Retinal on-pathway deficit in congenital disorder of glycosylation due to phosphomannomutase deficiency.
    Thompson DA; Lyons RJ; Liasis A; Russell-Eggitt I; Jägle H; Grünewald S
    Arch Ophthalmol; 2012 Jun; 130(6):712-9. PubMed ID: 22801829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Skin manifestations of protein glycosylation deficiency, the CDG (carbohydrate deficient glycoprotein) type 1 syndrome].
    Vabres P; Sevin C; Amoric JC; Odièvre MH; Saudubray JM; de Prost Y
    Ann Dermatol Venereol; 1998 Oct; 125(10):715-6. PubMed ID: 9835963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of PMM2 gene variant in an infant with congenital disorders of glycosylation type 1a].
    Wu R; Qiu K; Li D; Li Y; Deng B; Luo X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Apr; 36(4):314-317. PubMed ID: 30950015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality.
    Kranz C; Basinger AA; Güçsavaş-Calikoğlu M; Sun L; Powell CM; Henderson FW; Aylsworth AS; Freeze HH
    Am J Med Genet A; 2007 Jun; 143A(12):1371-8. PubMed ID: 17506107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological Chaperoning: A Potential Treatment for PMM2-CDG.
    Yuste-Checa P; Brasil S; Gámez A; Underhaug J; Desviat LR; Ugarte M; Pérez-Cerdá C; Martinez A; Pérez B
    Hum Mutat; 2017 Feb; 38(2):160-168. PubMed ID: 27774737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).
    García-López R; de la Morena-Barrio ME; Alsina L; Pérez-Dueñas B; Jaeken J; Serrano M; Casado M; Hernández-Caselles T
    PLoS One; 2016; 11(7):e0158863. PubMed ID: 27415628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2.
    Andreotti G; Monti MC; Citro V; Cubellis MV
    PLoS One; 2015; 10(10):e0139882. PubMed ID: 26488408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal cardiac ultrasound finding in congenital disorder of glycosylation type 1a.
    Malhotra A; Pateman A; Chalmers R; Coman D; Menahem S
    Fetal Diagn Ther; 2009; 25(1):54-7. PubMed ID: 19176971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia.
    Arnoux JB; Boddaert N; Valayannopoulos V; Romano S; Bahi-Buisson N; Desguerre I; de Keyzer Y; Munnich A; Brunelle F; Seta N; Dautzenberg MD; de Lonlay P
    Mol Genet Metab; 2008 Apr; 93(4):444-9. PubMed ID: 18093857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of whole exome sequencing to a rare inherited metabolic disease with neurological and gastrointestinal manifestations: a congenital disorder of glycosylation mimicking glycogen storage disease.
    Choi R; Woo HI; Choe BH; Park S; Yoon Y; Ki CS; Lee SY; Kim JW; Song J; Kim DS; Kwon S; Park HD
    Clin Chim Acta; 2015 Apr; 444():50-3. PubMed ID: 25681648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.